ConductScience.org, home

Paper38889481

Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.

Schmithals C and 18 others. EBioMedicine, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice. Papers, record 38889481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38889481

Download JSON
Cell line
Hep-G2496 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.
PubMed
Journal
EBioMedicine
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.52, provisional
iCite
Revised in PubMed
2026-01-27
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schmithals CChristian
2Kakoschky BBianca
3Denk DDominic
4von Harten MMaike
5Klug JHJan Henrik
6Hintermann EEdith
7Dropmann AAnne
8Hamza EEman
9Jacomin ACAnne Claire
10Marquardt JUJens U
11Zeuzem SStefan
12Schirmacher PPeter
13Herrmann EEva
14Christen UUrs
15Vogl TJThomas J
16Waidmann OOliver
17Dooley SSteven
18Finkelmeier FFabian
19Piiper AAlbrecht

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Phosphoric Diester HydrolasesMajor topic
Carcinoma, HepatocellularMajor topic
Disease Models, AnimalMajor topic
Liver NeoplasmsMajor topic
Animals
Mice
alpha-Fetoproteins
Male
Humans
Cell Line, Tumor
Prostatic Neoplasms
Oligopeptides
Lysophospholipase D

Source PubMed

Download CSV of topics

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118363553Neuropilins: structure, function and role in disease.Biochem J2008https://conductscience.org/library/papers/18363553PubMed
229753567Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice.J Autoimmun2018https://conductscience.org/library/papers/29753567PubMed
322745587Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels.Neoplasia2012https://conductscience.org/library/papers/22745587PubMed
435803295CEND-1: a game changer for pancreatic cancer chemotherapy?Lancet Gastroenterol Hepatol2022https://conductscience.org/library/papers/35803295PubMed
535676420Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.Nat Rev Gastroenterol Hepatol2022https://conductscience.org/library/papers/35676420PubMed
633986122Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation.J Immunother Cancer2021https://conductscience.org/library/papers/33986122PubMed
712143051Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study.Hepatology2002https://conductscience.org/library/papers/12143051PubMed
819962669Tissue-penetrating delivery of compounds and nanoparticles into tumors.Cancer Cell2009https://conductscience.org/library/papers/19962669PubMed
91707140Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.N Engl J Med1991https://conductscience.org/library/papers/1707140PubMed
1037315449A comprehensive evaluation of full-spectrum cell-free RNAs highlights cell-free RNA fragments for early-stage hepatocellular carcinoma detection.EBioMedicine2023https://conductscience.org/library/papers/37315449PubMed
1126239478Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.Cancer Res2015https://conductscience.org/library/papers/26239478PubMed
128642308Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin.J Exp Med1996https://conductscience.org/library/papers/8642308PubMed
1320378772Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.Science2010https://conductscience.org/library/papers/20378772PubMed
1412514785Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.Hum Pathol2002https://conductscience.org/library/papers/12514785PubMed
1518474629Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.J Exp Med2008https://conductscience.org/library/papers/18474629PubMed
1628167508Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition.Clin Cancer Res2017https://conductscience.org/library/papers/28167508PubMed
1728414297Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer.J Clin Invest2017https://conductscience.org/library/papers/28414297PubMed
1816177780Pathophysiological consequences of VEGF-induced vascular permeability.Nature2005https://conductscience.org/library/papers/16177780PubMed
1933538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
2033947161Neuropilin 1 Regulation of Vascular Permeability Signaling.Biomolecules2021https://conductscience.org/library/papers/33947161PubMed

See all 54 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42983536Metabolic-extracellular matrix crosstalk in hepatocellular carcinoma: mechanisms and targeted intervention.Cell Commun Signal2026https://conductscience.org/library/papers/42983536PubMed
41704422Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinoma.JHEP Rep2026https://conductscience.org/library/papers/41704422PubMed
39931738Vascular endothelial cell injury: causes, molecular mechanisms, and treatments.MedComm (2020)2025https://conductscience.org/library/papers/39931738PubMed
39789733Population Pharmacokinetic Modeling of Certepetide in Human Subjects With Metastatic Pancreatic Ductal Adenocarcinoma.Clin Pharmacol Drug Dev2025https://conductscience.org/library/papers/39789733PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38889481

GET https://conductscience.org/api/papers/v1/38889481/references?page=2